default author photo

Haruko Daga

Osaka City General Hospital

Japan

SCHOLARLY PAPERS

3

DOWNLOADS

113

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Daily low-dose carboplatin or weekly carboplatin plus nab-paclitaxel for concurrent chemoradiotherapy in older patients with locally advanced non-small cell lung cancer (JCOG1914): A randomized phase 3 trial

Number of pages: 42 Posted: 05 Dec 2025
affiliation not provided to SSRN, Shizuoka Cancer Center - Division of Thoracic Oncology, University of Tokyo - Department of Biostatistics and Bioinformatics, Shizuoka Cancer Center, affiliation not provided to SSRN, Shizuoka Cancer Center, Nagoya University, National Cancer Center Hospital East, National Cancer Center Hospital, National Hospital Organization Nagoya Medical Center, Hiroshima University - Hiroshima University Hospital, Kurashiki Central Hospital - Department of Respiratory Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, Kanagawa Cancer Center, affiliation not provided to SSRN, Kansai Medical University, Kurume University - Department of Internal Medicine, Kyushu University, National Center for Global Health and Medicine, Niigata Cancer Center Hospital, Osaka City General Hospital, Kyoto University, affiliation not provided to SSRN, National Cancer Center Hospital, National Cancer Center Hospital, Kyushu University - Kyushu University Hospital and Shizuoka Cancer Center
Downloads 54 (1,031,043)

Abstract:

Loading...

locally advanced, Non-small cell lung cancer (NSCLC), older patients, chemoradiotherapy, daily low-dose carboplatin, carboplatin plus nab-paclitaxel

2.

Longitudinal Analysis Reveals the Impact of Adjuvant Cytotoxic Chemotherapy in Egfr-Mutated Lung Cancer: A Combined Analysis of Phase Iii Studies

Number of pages: 36 Posted: 15 Nov 2024
Wakayama Medical University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Niigata Cancer Center Hospital, Hiroshima City Hiroshima Citizens Hospital, affiliation not provided to SSRN, Aichi Cancer Center, Osaka City General Hospital, Sendai Kousei Hospital - Department of Pulmonary Medicine, affiliation not provided to SSRN, Shizuoka Cancer Center - Division of Thoracic Oncology, Wakayama Medical University - Department of Pulmonary Medicine and Medical Oncology, affiliation not provided to SSRN, National Cancer Center Hospital East - Department of Thoracic Surgery and affiliation not provided to SSRN
Downloads 40 (1,183,237)

Abstract:

Loading...

epidermal growth factor receptor mutation (EGFR), EGFR-TKI, and adjuvant therapy

3.

Adjuvant Chemotherapy Intensity and Prognosis in Completely Resected High-Grade Neuroendocrine Lung Carcinoma: A Post Hoc Analysis of JCOG1205/1206

Number of pages: 43 Posted: 22 Apr 2026
Kanagawa Cancer Center, Shizuoka Cancer Center - Division of Thoracic Oncology, National Cancer Center Hospital, Kansai Medical University, University of Tokyo - Department of Surgery, Hiroshima University, affiliation not provided to SSRN, National Cancer Center Hospital, National Cancer Center Hospital, National Cancer Center Hospital, Osaka City General Hospital, Niigata Cancer Center Hospital, affiliation not provided to SSRN, Dokkyo Medical University, National Cancer Center Hospital East - Department of Thoracic Surgery, National Cancer Center Hospital, affiliation not provided to SSRN, Kyushu University - Kyushu University Hospital and National Cancer Center Hospital - Department of Thoracic Surgery
Downloads 19 (1,470,786)

Abstract:

Loading...

high-grade neuroendocrine carcinoma, Small-cell lung cancer, large-cell neuroendocrine carcinoma, cisplatin, irinotecan, etoposide, Relative dose intensity